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1931–2013Robert P. PerryOn July 15th, Robert Palese Perry—‘‘Bob’’
to those who knew him—passed away
at the age of 82. Bob was a pioneer in
studying gene transcription in mammalian
cells, a wonderful mentor to his pre- and
postdoctoral students, and a compas-
sionate family man. He leaves behind his
wife Zoila, a well-known sculptor with
whom he enjoyed a happy marriage for
57 years, his two daughters Adele and
Monique, his son Rocco, and seven
grandchildren.
Of Italian origin—his grandparents
moved from Trivigno, a small town in
Southern Italy, to the United States in the
late 19th century—Bob grew up in Chi-
cago. He earned his bachelor degree as
a major in mathematics from North-
western University in 1951 and his PhD in
biophysics from the University of Chicago
in 1956. Thereafter, he did postdoctoral
work at theOakRidgeNational Laboratory
in Tennessee, at theUniversity of Pennsyl-
vania, and at the Free University of Brus-
sels in Belgium. In 1960, Bob was hired
as an independent investigator by the
Fox Chase Institute for Cancer Research
(now part of the Fox Chase Cancer
Center). He remained faithful to this insti-
tution until he retired in 2004. From 1971
to 1974 he served as Associate Director
of the Fox Chase Institute for Cancer
Research. In 1977 Bob was elected to
the U.S. National Academy of Sciences,
Section of Cellular and Developmental
Biology, for his exceptional research con-
tributions in this field. In 1994 he was
nominated to be the first occupant of the
Stanley P. Reimann Endowed Chair in
Oncology Research, and in 1995 he
received the Stanley P. Reimann Honor
Award. Stanley P. Reimann was the
founder of the Fox Chase Institute for
Cancer Research, and these were the
highest award given by the Institute.
During the BC (Before Cloning) era
there were probably fewer than a dozen
laboratories worldwide doing cutting-
edge research on gene transcription in
mammalian cells. Among them were the
laboratories of Bob Perry, James E. Dar-
nell Jr. at Rockefeller University, SheldonPenman at the Massachusetts Institute
of Technology, and Robert G. Roeder,
then at Washington University School of
Medicine in St. Louis. For today’s grad-
uate students and postdocs, it is virtually
impossible to imagine how important dis-
coveries could be made with the Stone
Age tools then at hand. Even in bacteria
and bacteriophages, the common
research models at the time, very little
was known about the synthesis and
decay of RNA molecules. When Klaus
Scherrer, then a postdoc in Jim Darnell’s
laboratory, proudly told Jim Watson in
the early 60s that he was about to initiate
studies on RNA metabolism in mamma-
lian cells, Watson replied ‘‘To work with
animal cells, you’ve got to be a hero or a
fool!’’ Soon thereafter, however, the labo-
ratories of Bob Perry and Jim Darnell
generated a big wave of excitement about
mammalian RNA synthesis. Thus, in 1962,
Bob reported in a single author PNAS pa-
per that ribosomal RNA was made in the
nucleolus. This important discovery was
based on his finding that low doses of
the drug actinomycin D specifically in-
hibited incorporation of [3H] labeled cyti-
dine into nucleolar and ribosomal RNA,
as revealed by autoradiography andCell 15sucrose gradient centrifugation, respec-
tively. In the same year, Klaus Scherrer
and Jim Darnell found that pulse-labeled
RNA sedimented much more rapidly on
sucrose gradients than RNAs labeled for
extended time periods. Further RNA-la-
beling and size fractionation experiments
performed by the groups of Perry, Darnell,
and Penman suggested that both ribo-
somal RNA and mRNA are processed
from large precursors.
Just before molecular biologywas revo-
lutionized by recombinant DNA technol-
ogy, Bob made another groundbreaking
discovery, namely that mRNA molecules
contain methylated base and sugar resi-
dues. This findingwaspublished in the first
issue ofCell in 1974, for which Bob served
on the founding editorial board. This dis-
covery resulted in the identification of the
50-terminal m7GpppNp CAP structure
and internalm6A residues. In a short article
appearing a few months later in Cell, Bob
Perry; Fritz Rottman, at Michigan State
University; and Aaron Shatkin, at the
Roche Institute of Molecular Biology,
speculated on the chemical structure of
the 50-terminal methylated oligonucleotide
sequences of mRNA. Based on simple ex-
periments conducted in the three labora-
tories, the authorsproposeda50 to 50 pyro-
phosphate linkage between an m7G
residue and the first transcribed nucleo-
tide. Furthermore, they predicted that the
first, and sometimes the second tran-
scribed nucleotides carry methyl groups
at the 20 positions of their ribose moieties.
They almost got it right, except that three
rather than two phosphates bridge the
m7G to the first transcribed nucleotide.
Perhaps they did not take into account
that m7G is positively charged at neutral
pH and therefore compensated for the
negative charge contributed by the third
phosphateduringDEAESepharose ionex-
change chromatography. Bob’s last
important contribution in the BC era was
his demonstration that large nuclear RNA
molecules, known as heterogeneous
nuclear RNA (hnRNA), harbor the same
CAP structures as mRNA. This finding
was taken as further support for the pre-
cursor-product relationship between
hnRNA and mRNA. However, this view
was not entirely satisfactory at the time,
because hnRNA and mRNA also shared
30-terminal poly(A) sequences. So the
question as to whether mRNAs were4, August 29, 2013 ª2013 Elsevier Inc. 953
derived from 50-terminal or 30-terminal
hnRNA sequences remained open. The
enigma was finally demystified in 1977
with the discovery of pre-mRNA splicing
by Richard Roberts and Philip Sharp.
Using adenovirus as a model system—in
theBCeraviral geneswere theonlyprotein
encodinggenesamenable to experimental
dissection in mammalian cells—Roberts
and Sharp independently came to the
conclusion that mRNA was processed by
the removal of internal rather than external
sequences. One of us (U.S.) was in the lab-
oratory when Bob Perry breathlessly
stormed through the door to tell us about
his exciting phone call with Phil Sharp.
When molecular cloning techniques
became available, Bob soon realized
that his mRNA turnover work had to
switch from global to specific analysis. In
other words, to make progress he needed
model systems permitting the analysis of
individual gene products. To this end
Oscar Valbuena, a graduate student,
and Kenneth Marcu, a postdoctoral
fellow, initiated work on a plasmacytoma
cell line producing light and heavy chain
immunoglobulin mRNAs in large quanti-
ties. With the mission to clone cDNA
copies for these mRNAs enriched in the
size-fractionated RNA samples prepared
by Oscar and Ken, one of us (U.S.) was
sent to the Carnegie Institution of Embry-
ology in Baltimore, headed by Donald D.
Brown, another icon in eukaryotic gene
transcription. With a lot of help by Yasumi
Ohshima and Yoshiaki Suzuki this was
eventually accomplished, and we could
now use these DNA probes to follow the
fates of specific immunoglobulin pre-
mRNAs. The consecutive studies on954 Cell 154, August 29, 2013 ª2013 Elsevieimmunoglobulin gene transcription and
mRNA processing resulted in a series of
high-impact articles published in Cell,
Nature, and PNAS. In parallel one of us
(O.M.), who joined the laboratory in the
late 70s, reanimated work on ribosome
biogenesis in Bob’s group. He cloned
cDNAs for several ribosomal proteins
and used them to study the structure
and expression of the corresponding
genes. Again, these studies culminated
in several high-profile research papers
published in Cell and other prestigious
journals. In the early 1990s, Bob fortu-
itously discovered a mammalian cDNA
specifying a polypeptide, dubbed
‘‘CHD-1,’’ with homology to yeast and
Drosophila chromatin remodeling pro-
teins. This was one of the first chromatin
remodelers to be discovered in mamma-
lian cells, and, remarkably, Bob found
that it was distinct from theoriginal remod-
elers by having a chromodomain in
addition to the SWI/SNF ATPase domain.
Although Bob immediately recognized
that the chromodomain provided a link to
chromatin compaction states, it took
another decade until others appreciated
that the chromodomain allows recruitment
of the remodeler to sites of core histone
methylation. CHD proteins now constitute
a family in diverse complexes that regulate
chromatin structure and gene expression
in all eukaryotes. Curiously, both the first
and the last paper Bob published as an
investigator at the Fox Chase Cancer
Center deal with ribosome biogenesis,
and both he signed as the sole author.
While thefirst focuseson theRNAmoieties
of these tiny protein-production factories,
the last reviews the possible mechanismsr Inc.accounting for the balanced production
of the 79 ribosomal proteins. Through
most of his rich research career, Bob was
assisted by Dawn Kelley, a very talented
and exceedingly meticulous research
associate who taught pre-and postdocs
proper working habits. Considering that
some of the RNA-labeling experiments
conducted in Bob’s lab during the 70s
required hundreds of millicuries of [32P]
orthophosphate, the close surveillance of
the sometimes too impatient rookies by a
severe (but beloved) ‘‘laboratory mother’’
was an absolute necessity.
Bob’s advice in choosing a scientific
object to work on can be summarized by
Gordon’s First Law: If a project is not
worth doing at all, it’s not worth doing
well. While he had amost amiable person-
ality, he was allergic to vague and poorly
articulated arguments—‘‘fuzzy thinking,’’
as he called it. As leader of the Cell and
Developmental Biology Program at Fox
Chase in the 1990s, he led a tight group
of faculty that had to learn to become
comfortable with critical analysis and
deep thought about their science. Bob
loved the challenge of hearing a new
idea and questioning its presumptions
and implications. He would smile as he
volleyed a tough question at the speaker
in the weekly faculty science talks. How-
ever, he would equally relish a strong
reply. At the end of the 1990s, Bob step-
ped down as leader of the group but
remained active intellectually and was
consistently positive and helpful after
one of us (K.S.Z.) took the helm.
Wewill dearlymiss Bob as a superb sci-
entist, a wonderful mentor, and a most
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